HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH - DE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 24
As coordinator: 6
As participant: 13
Sole participant: 5
Coordinator / Participant Ratio: 0.46*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 1.674.806 38.890.836 3.458.110 2 4
2021 8.442.649 20.099.333 4.102.936 4 2
2020 17.908.214 53.439.838 8.042.601 4 5
2019 8.391.240 17.299.559 3.507.121 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
LEIDS UNIVERSITAIR MEDISCH CENTRUM7
COMMISSARIAT A L'ENERGIE ATOMIQUE5
UNIVERSITY OF BERGEN5
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
UNIVERSITEIT UTRECHT4
UNIVERSITY COLLEGE LONDON4
UNIVERSITY OF OSLO4
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
DANMARKS TEKNISKE UNIVERSITET3
EIDGENOESSISCHES DEPARTEMENT DES INNERN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT3
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA3
MEDIZINISCHE UNIVERSITAET WIEN3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
UNIVERSIDADE NOVA DE LISBOA3
UNIVERSITA DEGLI STUDI DI SIENA3
UNIVERSITE D'AIX MARSEILLE3
UNIVERSITEIT ANTWERPEN3
WAGENINGEN UNIVERSITY3
ASA SPEZIALENZYME2
ATOS ORIGIN INTEGRATION SAS2
AUSTRIAN RESEARCH CENTERS SIEBERDORF2
AVIAGIS NV2
BAYER2
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES2
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LE DEVELOPPEMENT2
CENTRUM VOOR INNOVATIE EN STIMULATIE VAN MEDICIJNONTWIKKELING LEUVEN VZW2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE2
EATRIS ERIC2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN VACCINE INITIATIVE EV2
EUROVACC FOUNDATION2
FORSCHUNGSVERBUND BERLIN EV2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA2
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ2
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA2
GENIBET BIOPHARMACEUTICALS2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSERM TRANSFERT2
INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES2
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT2
INSTITUT PASTEUR2
INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS POLISH ACADEMY OF SCIENCES2
INSTITUTO DE BIOLOGIA MOLECULAR E CELULARIBMC2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
INSTRUCTERIC2
INSTYTUT CHEMII BIOORGANICZNEJ PAN2
ISTITUTO SUPERIORE DI SANITA2
JANSSEN PHARMACEUTICA NV2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MASARYKOVA UNIVERZITA2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
SCLAVO VACCINES ASSOCIATION2
STATENS SERUM INSTITUT2
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER2
STICHTING CENTRE FOR HUMAN DRUG RESEARCH2
STIFTELSEN SINTEF2
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER2
SWISS TROPICAL INSTITUTE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITE DE LIEGE2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF TURKU2
UNIVERZITA PALACKEHO V OLOMOUCI2
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE2
VACCINE FORMULATION INSTITUTELTD2
WEIZMANN INSTITUTE OF SCIENCE2
2CONTROL APS1
ABBVIE INC1
ABO AKADEMI1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACOSOL1
ADDITESS ADVANCED INTEGRATED TECHNOLOGY SOLUTIONS & SERVICES1
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS1
AGRICULTURAL RESEARCH COUNCIL1
AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM1
AIBIOPHARMA1
AICURIS ANTIINFECTIVE CURES1
ARTTIC1
ARTTIC INNOVATION1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE1
ASTELLAS PHARMA EUROPE BV1
ATRC AURIGON TOXICOLOGIAI KUTATOKOZPONT KORLATOLT FELELOSSEGU TARSASAG1

Constancy:

Total number of partners: 456
Partner loyalty:
Frequent Partner: (> 2 projects): 83
Rare Partner: 373
Frequent / Rare Partner Ratio: 0.22

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Impact and viability of a novel mass PCR testing method as a pandemic-fighting strategy PCR-4-ALLparticipant3.397.6114
2022-10-01Strategies and Technologies for United and Resilient Critical Infrastructures and Vital Services in Pandemic-Stricken Europe SUNRISEparticipant9.544.98641
2022-08-01Biodiversity Conservation to Mitigate the risks of emerging infectious diseases BCOMINGparticipant4.949.61514
2022-05-01Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense COVIDecodecoordinator1.500.0001
2022-02-01Integrated Services for Infectious Disease Outbreak Research ISIDOReparticipant20.998.624154
2022-01-01anti-pseudoMOnas aeruginosa biofilm NAno-in-hydroGEL MONAGELcoordinator174.8061
2021-09-01Pathogen-responsive hydrogels release antimicrobial vesicles for local infection treatment Gels4Bacparticipant1.499.3332
2021-09-01Innovations to accelerate vaccine development and manufacture Inno4Vacparticipant18.600.00041
2021-04-01Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques MYCOBIOMICScoordinator1.375.4008
2021-03-01European Network Linking Informatics and Genomics of Helper T cells in Tissues ENLIGHT-TENpluscoordinator4.067.52615
2021-02-01Real-time analysis of ribosomal frameshifting and its impact on immunity and disease T-FRAMEcoordinator1.499.8521
2021-01-01Cross-omics integration to identify modulators for improving vaccine efficacy ModVaccinecoordinator1.499.8711
2020-10-01Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer REpAIRparticipant1.999.6872
2020-08-01Indo-European Consortium for Next Generation Influenza Vaccine Innovation INCENTIVEcoordinator9.974.29421
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21628
2020-06-01Interrogating native CRISPR arrays to achieve scalable combinatorial screens and dissect genetic redundancy CRISPRcombocoordinator2.000.0001
2020-04-01Swift COronavirus therapeutics REsponse SCOREparticipant2.576.06310
2020-04-01Exploiting the methylerythritol phosphate pathway as a source of drug targets for novel anti-infectives MepAnticoordinator3.174.72511
2020-04-01COVID-19-Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research CORESMAcoordinator2.759.1957
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18643
2020-01-01THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B TherVacBparticipant10.425.68618
2019-07-01NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW GNA NOWparticipant12.299.99511
2019-06-01Vaccine for prevention and treatment of Trypanosoma cruzi infection CRUZIVAXcoordinator8.391.24011
2019-02-01Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond EU-OPENSCREEN-DRIVEparticipant4.999.56434